A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBI.
A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBI.
Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.
Peer-reviewed research, clinical studies, and scientific papers related to eFlow® Technology and inhaled therapies.
A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBI.
Some cystic fibrosis patients do not tolerate tobramycin dry powder inhalation.
Topical Drug Delivery in Chronic Rhinosinusitis Patients before and after Sinus Surgery Using Pulsating Aerosols.
Pulsating Aerosols - New Therapy Options for Upper Airway Diseases.
Assessing Modeled CO2 Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants.